Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
A popular dental local anesthetic is Articaine Hydrochloride. Many things impact its market. Makers, distributors, and healthcare personnel must comprehend how these things function.
More dental procedures, from easy cleanings to more complicated surgeries, mean that more people need the drug articaine hydrochloride. A lot more people will want this service if they know they need it and go to the dentist.
People are told not to use other kinds of painkillers but to use articaine hydrochloride instead. The doctors care a lot about how their patients feel and how quickly the sedation works. Because of this, the market puts a lot of value on the fact that this product can give both fast and strong anesthesia.
Oral technology has changed the things that contain articaine hydrochloride. They will be able to get and use the medicine more easily if it is given and offered more quickly. After this, the market will get bigger.
Business trends are based on what customers want, and more and more people want to have fun at the doctor. People usually choose articaine hydrochloride because it has fewer side effects. This is why people who work as therapists use it.
The Articaine Hydrochloride company has to follow a number of rules. Making things is a very strict business that needs to follow strict rules and get licenses to make safe and useful things. The market isn't working well for new businesses to begin with.
All of the big companies in the field are competing for a small part of the market. The articaine hydrochloride market can be changed by many things, such as new products, agreements, mergers and acquisitions, and other types of business joining together.
More dentists around the world are opening their doors, and more people are learning about better ways to put people to sleep during dental procedures. This is making the market for Articaine Hydrochloride grow quickly. It would be good for the market if more people in poor countries had mouth surgery.
People who need dental care and people who work in dentist offices both need to worry about cost-effectiveness. The price of articaine hydrochloride and the fact that it is used as a medicine both have an impact on the market, especially in places where prices tend to change often.
It is important to keep in mind that the Articaine Hydrochloride market is affected by the continuing research and development work that is being done to improve how this drug is made, distributed, and its bad effects. Through the process of research and development, companies can set themselves apart in the market and come up with new products.
Dental instruction and the promotion of dental goods both have an effect on the market. Dentistry professionals will be more likely to use Articaine Hydrochloride because it has so many benefits. This will cause the market to grow.
Market risks and constraints include side effects, legal issues, and competition from other anesthetics. Articaine Hydrochloride commercial success depends on eliminating these hazards.
 
Articaine Hydrochloride Market Highlights:
Articaine Hydrochloride Market Overview
The articaine hydrochloride market is expected to reach USD 1383.34 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.
Articaine is a form of a local amide anesthetic that is most commonly used in dentistry. The articaine is marketed as a colorless liquid in vials/cartridges (2ml in each vial/cartridge). It is available in two variants, i.e., Articaine-100 & Articaine-200. Articaine-200 is more potent than Articaine-100. The dosage can be based on the type and extent of surgical procedure, depth of anesthesia, degree of muscular relaxation, and condition of the patient. For pediatric patients, dosage based on their age, weight, the physical condition of the patient, and the extent of the surgical procedure.
The articaine hydrochloride industry is growing rapidly. Articaine, with its greater ability to diffuse through tissues, become a very widely used local anesthetic in the European and Canadian markets.
Market Dynamics
Articaine hydrochloride is the most popular local anesthetic for dentistry. For example, in Germany, around 97% of the anesthetic used by dentists is articaine hydrochloride. The growth of the market is likely to be driven by increasing incidences of dental caries and other periodontal diseases, advancement in dental anesthesia delivery system device, increasing the use of articaine for dental surgery, innovative nature of the dental anesthetics industry, and vigorous research and development efforts. Periodontal disease is one of the major dental diseases that influence human populations worldwide at high prevalence rates. Periodontal diseases are more prevalent in Asia-Pacific. Lack of the most basic oral health education and limited availability of simple interventions like pain relief and emergency care for acute infection and trauma to the vast majority of the population, especially in the rural areas are major reasons for the high incidences of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia-Pacific, including countries such as India, Bangladesh, Nepal, Malaysia, and Indonesia, suffer from dental decay. Furthermore, 40–59% of the population in China and Australia suffer from dental caries.
Some of the popular local anesthesia other than articaine are prilocaine, lidocaine, mepivacaine, and bupivacaine. The availability and usage of alternative products are likely to thwart the growth of the articaine hydrochloride market during the forecast period.
Articaine Hydrochloride Market Size, by End User, 2018 and 2025 (USD Million) Â 
Source: MRFR Analysis
Segmentation
The articaine hydrochloride market has been segmented into application and end user. Based on application, the global market has been segmented into infiltration, nerve block, and others. Based on end-user, the global market has been segmented into dental clinics, hospitals, and academics & research institutes. The dental clinics segment accounted for a market value of USD 798.5 million in 2018.
Key Players
The prominent players in the articaine hydrochloride market are 3M (US), Anhui BBCA Pharmaceutical Co., Ltd. (China), Dentsply Sirona (US), Inibsa Dental S.L.U (Spain), Jinan Chenghui Shuangda Chemical Co., Ltd. (China), Jinan Ruixing Pharmaceutical Technology Co., Ltd (China), Manus Aktteva Biopharma LLP (India), Pfizer Inc. (US), Pierrel S.p.A (Italy), Sanofi (France), Septodont (France), Siegfried AG (Switzerland), and Sigma Aldrich (US).
Some of the key strategies followed by the players operating in the articaine hydrochloride market were innovation, product development, acquisition, and expansion.
Asia-Pacific Articaine Hydrochloride Market Share, by Country, 2018 (%)  
Source: MRFR Analysis
Regional Analysis
The articaine hydrochloride market, based on region, is segmented into Europe, North America, Asia-Pacific, and the Middle East and Africa. The articaine hydrochloride market in Europe is the largest region in the market and is expected to develop continuously due to the increasing demand and focus on dental treatments. The growing awareness of preventative and corrective treatment in European countries is also one of the factors driving the growth of this market. The articaine hydrochloride market in Europe is mainly focusing on a new style of management system that would engage dental specialists to run more effective practices and permit them to concentrate on better clinical care.
North America accounted for the second-largest share in the articaine hydrochloride market. The increasing acceptance of the articaine by dental professionals is one of the factors for the growth of the articaine hydrochloride market in this region.
Asia-Pacific is one of the fastest-growing markets for articaine hydrochloride. Although Australia is dominating the Asia-Pacific market with high adoption of new technology and its usage of dental applications, China, Japan, and India are the countries mainly responsible for the exponential growth of the articaine hydrochloride market in Asia-Pacific. The demand for articaine hydrochloride in India offers several growth opportunities owing to the rising awareness of new applications. In Asia-Pacific, India accounted for a market share of 8.5% in 2018.
Key Updates
-
In March 2018, Dentsply Sirona Inc. announced the signing of a definitive agreement to acquire OraMetrix. Thus, the company aims to expand its product portfolio in the market.
-
In June 2016, Pierrel S.p.A. entered into a ten-year agreement with Safco Dental Supply Co. for the production and marketing of the anesthetic articaine in the US.
-
In June 2016, Septodont acquired the injectable dental anesthetic manufacturing plant from Dentsply International, located in Brazil.
Market Segmentation
Articaine Hydrochloride Market, by Application
- Infiltration
- Nerve Block
- Others
Articaine Hydrochloride Market, by End User
-
Dental Clinics - Hospitals
- Academics & Research Institutes
Articaine Hydrochloride Market, by Region
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Western Europe
- North America
- US
- Canada
- Asia-Pacific
- Australia
- Japan
- China
- India
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Available Additional Customizations
-
Additional Companies- Transo-Pharm Handels GmbH
- Orgapharm
- Axyntis
- Benechim s.p.r.l.
- Green Stone Swiss Co., Ltd
- Moehs Iberica SL
- Supply & Demand Analysis
- Investment Opportunities and Mega Trends in the market
Intended Audience
- Drug manufacturers and distributors
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Pharmaceutical companies
- Anesthetic compounds manufacturers
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
